United Kingdom-Bristol: Multi-Apheresis and Extracorporeal Photopheresis Systems

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: 040642/S 000-2025
Nature of contract: Supply contract
Procedure: Not specified
Regulation of procurement: Not applicable
Type of bid required: Not applicable

UKPGA UK2: Preliminary Market Engagement Notice

I) Contracting Authority/Entity
I.1) Name and addresses
Official name: NHS Blood and Transplant
National registration number: PDBY-6395-VWBP

Postal address: 500 North Bristol Park
Town: Bristol
Region: Bath and North East Somerset, North Somerset and South Gloucestershire
Postal code: BS34 7QH
Country: United Kingdom

Contact Person: Rowena Thomas
Telephone: 07553520488
Email: rowena.thomas@nhsbt.nhs.uk

Internet address

I.4) Type of the contracting authority
Public authority – central government

II) Object
II.1.1) Title
Multi-Apheresis and Extracorporeal Photopheresis Systems
Reference number: C376077

II.1.3) Type of contract
Supplies

II.1.4) Short description
NHS Blood and Transplant (NHSBT) is a Special Health Authority and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals. The NHSBT Therapeutic Apheresis Service (TAS) provide lifesaving and life-enhancing therapies to adults and children across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 10 dedicated units across England and Wales (Bristol, London, Oxford, Leeds, Sheffield, Liverpool, Manchester, Birmingham, Plymouth, Cambridge and Liverpool) with each unit led by a team of specialist medical and nursing staff. Prior to commencing a formal procurement process and to help inform strategy requirements, NHSBT would like to consult the market to establish the level of interest for the purchase of therapeutic apheresis machines, consumables and maintenance, to support provision of new Therapeutic Apheresis Systems for Extracorporeal Photopheresis (ECP), Apheresis Collection, Exchange and Depletion Procedures (including Bone Marrow), and associated consumables and maintenance. Requirements also include consumables, maintenance and repair of existing NHSBT owned Cellex ECP Machines and Optia Multi-Apheresis Machines.

II.1.5) Estimated Total Value
Value (including VAT)
78,000,000
Value (excluding VAT)
65,000,000
Currency
GBP

II.2) Description
II.2.1) Title
Contract/Lot No
1

II.2.2) CPV codes
Main CPV codes
33100000
33140000
50421000

II.2.3) Place of performance
NUTS code
UKC – NORTH EAST (ENGLAND)
UKD – NORTH WEST (ENGLAND)
UKF – EAST MIDLANDS (ENGLAND)
UKG – WEST MIDLANDS (ENGLAND)
UKH – EAST OF ENGLAND
UKJ – SOUTH EAST (ENGLAND)
UKK – SOUTH WEST (ENGLAND)

II.2.7) Contract dates (estimated)
Start
2027-02-01 00:00
End
2037-02-01 23:59
Duration
10 years 1 day

II.3) Estimated date of publication of contract notice
2026-03-01 23:59

VI) Complementary information
Link to source/bidding documents

VI.5) Date of dispatch of this notice
2025-07-16 16:24

VI.6) Engagement information
Engagement deadline
2025-08-18 23:59
Engagement process description
NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held during September 2025. Any interested organisations are asked to contact rowena.thomas@nhsbt.nhs.uk by no later than 17:00 on the 18th August 2025 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria, timescales, may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.